tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
:HALO
US Market
Advertisement

Halozyme (HALO) Technical Analysis

Compare
1,033 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
3Neutral
3Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is 0.99, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 56.57, while Halozyme Therapeutics’s (HALO) share price is $58.24, making it a Buy.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 56.10, while Halozyme Therapeutics’s (HALO) share price is $58.24, making it a Buy.

Halozyme (HALO) Pivot Points

Jul 29, 2025, 04:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
57.52
58.02
58.39
58.89
59.26
59.76
60.13
Fibonacci
58.02
58.35
58.55
58.89
59.22
59.42
59.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Jul 29, 2025, 04:15 AM
Period
Simple
Exponential
MA5
57.81Buy
58.03Buy
MA10
57.55Buy
57.48Buy
MA20
56.10Buy
56.57Buy
MA50
54.50Buy
56.10Buy
MA100
57.96Buy
56.48Buy
MA200
55.39Buy
55.84Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 57.48, while Halozyme Therapeutics’s (HALO) share price is $58.24, making it a Buy.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 56.48, while Halozyme Therapeutics’s (HALO) share price is $58.24, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $58.24 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 54.50, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $58.24 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 57.96, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $58.24 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 55.39, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Jul 29, 2025, 04:15 AM
Name
Value
Implied Action
RSI (14)
59.70
Neutral
STOCH (9,6)
80.21
Sell
STOCHRSI (14)
86.71
Sell
MACD (12,26)
0.99
Sell
ADX (14)
18.78
Buy
Williams %R
-21.78
Buy
CCI (14)
84.59
Neutral
ATR (14)
1.39
-
Ultimate Oscillator
47.90
Neutral
ROC
7.41
Buy
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 59.70, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 18.78, creating a Buy signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is 84.59, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is 7.41, creating a Buy signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Strong Buy.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 59.70, which suggests HALO is a Neutral.
      What is HALO’s MACD?
      HALO’s MACD is 0.99, which suggests HALO is a Sell.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 57.81, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 56.10, which suggests HALO is a Buy.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 54.50, which suggests HALO is a Buy.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 55.39, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -21.78, which suggests HALO is a Buy.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is 84.59, which suggests HALO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis